s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Tuesday, April 29, 2025
Accession number
0001641172-25-006667
Documents
Prospectus
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header